Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
When Should I Change My Budget During The Month provides practical timing advice to adjust your plan responsibly as circumstances evolve.
26,475 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A quarterly data snapshot reveals moves by the wealthiest fund managers. This piece dives into why these billionaire ...
Novo Nordisk slashing prices is drawing attention from investors who wonder how a price cut could actually lift the s...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Berkshire Hathaway buying back stock isn’t just a headline. It reflects how the company views its own value and how i...
Unlock a practical, reader-friendly breakdown of Rapid Micro's Q1 2026 results. This guide translates the transcript ...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...
A high-profile former AI czar challenges Sanders’ 50% government stake plan for AI firms, warning that nationalizatio...
Greg Abel could be quietly changing Berkshire Hathaway’s approach. This deep dive explains what his moves might look ...
A China-based AI software company is powering a sharp move in the market. This article breaks down why yuanbao stock ...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Bitcoin steadies in the upper $77,000s as markets weigh renewed U.S.-Iran talks. Oil prices and Fed pricing will dete...